Singapore markets closed

Agios Pharmaceuticals, Inc. (AGIO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
47.52-0.23 (-0.48%)
At close: 4:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
203,196
203,196
117,912
94,387
43,011
Cost of revenue
-
2,805
1,317
1,397
-
Gross profit
-
200,391
116,595
92,990
-
Operating expenses
Research development
377,699
367,470
410,894
341,324
292,681
Selling general and administrative
150,986
149,070
132,034
114,145
71,124
Total operating expenses
528,685
516,540
542,928
455,469
363,805
Operating income or loss
-328,294
-316,149
-426,333
-362,479
-320,794
Interest expense
-
17,832
-
-
-
Income before tax
-335,448
-327,370
-411,472
-346,028
-314,670
Income from continuing operations
-335,448
-327,370
-411,472
-346,028
-314,670
Net income
1,591,472
-327,370
-411,472
-346,028
-314,670
Net income available to common shareholders
1,591,472
-327,370
-411,472
-346,028
-314,670
Basic EPS
-
-4.74
-6.86
-6.03
-6.75
Diluted EPS
-
-4.74
-6.86
-6.03
-6.75
Basic average shares
-
68,998
59,995
57,418
46,588
Diluted average shares
-
68,998
59,995
57,418
46,588
EBITDA
-
-299,554
-418,246
-355,307
-314,362